Thromb Haemost 2023; 123(01): 123-130
DOI: 10.1055/s-0042-1760263
Editors' Choice

Thrombosis and Haemostasis 2022 Editors' Choice Papers

Christian Weber
1   Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany
2   German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
3   Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands
Xavier Blanchet
1   Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany
Gregory Y. H. Lip
4   Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom
5   Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
› Author Affiliations

The Editor's Choice from Thrombosis and Haemostasis as well as from its open access companion journal TH Open highlights the articles and reviews of the year that have achieved the greatest resonance among our readers. In 2022, the coronavirus disease 2019 (COVID-19) has remained an important topic mandating the need to interrogate the emergence and management of new viral infections.[1] Several of our most highly cited papers have dealt with bleeding and thrombotic complications, their diagnosis, and management in several pathologies, including cancer and pulmonary and COVID-19-associated cardiovascular diseases (CVDs).[2] [3] [4] [5] [6] Particular interest was also instigated by a new promising concept of the holistic or integrated care management approach of patients with stroke along with the definition of an “aortovascular hub” aligned with an integrated health care system.[7] [8]

Publication History

Article published online:
10 January 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany